A carregar...

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies

BH3 mimetics are novel targeted drugs with remarkable specificity, potency and enormous potential to improve cancer therapy. However, acquired resistance is an emerging problem. We report the rapid development of resistance in chronic lymphocytic leukemia cells isolated from patients exposed to incr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Al-Zebeeby, Aoula, Vogler, Meike, Milani, Mateus, Richards, Caitlin, Alotibi, Ahoud, Greaves, Georgia, Dyer, Martin J.S., Cohen, Gerald M., Varadarajan, Shankar
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6518917/
https://ncbi.nlm.nih.gov/pubmed/30467206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.204701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!